Nature, Published online: 16 May 2025; doi:10.1038/d41586-025-01596-w
A baby boy is thriving after receiving a CRISPR therapy to treat his specific disease-causing mutation. Plus, the FDA plans to phase out animal toxicity testing and physicists are trialling a portable antimatter containment system.
0 Comments